⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Quantel Medical and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Quantel Medical
↗Cournon-d'Auvergne, France
Quantel Medical is a global leader in the development and manufacturing of ophthalmic medical devices, specializing in laser and ultrasound technologies for the diagnosis and treatment of eye diseases. Founded in 1993, the company focuses on addressing the four main causes of blindness: cataract, glaucoma, diabetic retinopathy, and macular degeneration, as well as dry eye disease.
As a key brand within the Lumibird Medical division of the Lumibird Group, Quantel Medical leverages significant R&D capabilities to produce innovative diagnostic and therapeutic solutions. The company maintains a strong international presence with direct operations in France and the U.S., supported by a global network of distributors in over 110 countries.
CLASSIFICATION
SIZE & FINANCIALS
Employees:201-500
Revenue:$100M-$200M
Founded:1993
Ownership:subsidiary
Status:operating
FUNDING
Total Raised:$0
STOCK
Exchange:Euronext
Ticker:LBIRD
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (Medical Device Manufacturer)
Modalities:Laser therapy, Ultrasound diagnostics
Active Trials:1
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Lumibird Group
Acquired By:Lumibird Group (via Lumibird Medical)
Subsidiaries:Ellex, Optotek Medical
Key Partnerships:Lumibird Medical Group (Internal integration with Ellex and Optotek)
COMPETITION
Position:Leader
Competitors:Iridex, Alcon, D.O.R.C., DGH Technology, Tomey USA, Sonomed Escalon
LEADERSHIP
Key Executives:
Jean-Marc Gendre - CEO of Lumibird Medical
LINKS
Website:quantelmedical.fr
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Quantel Medical. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.